Evolus, Inc.
Market Cap
$319.44M
P/E Ratio
-6.14
EPS
$-0.80
Dividend Yield
0.00%
52-Week Range
$4.09 — $13.66
Volume
1.30M
Avg Volume
1.32M
Beta
1.01
P/E (TTM)
-6.14
Forward P/E
—
PEG Ratio
-0.55
P/S (TTM)
1.15
P/B (TTM)
-14.73
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
2.68%
ROA (TTM)
-0.23%
ROIC
—
Gross Margin
0.66%
Operating Margin
-0.13%
Net Margin
—
Debt/Equity
-6.32
Current Ratio
1.90
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.01%
EPS Growth (5Y)
+0.06%
Sales Growth (3Y)
+0.39%
Sales Growth (5Y)
+0.51%
EPS Est (This Year)
$-0.17
EPS Est (Next Year)
$0.22
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.83
Price Target Range
Consensus Target: $15.00(205.5% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
64.82M
Float
49.66M
Free Float %
76.61%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
2018-02-08
Employees
372
CEO
David Moatazedi
Index Membership
—
Website
https://www.evolus.com
Evolus, Inc. (EOLS) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $319.44M, a P/E ratio of -6.14, EOLS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare EOLS against other stocks using dozens of fundamental and technical filters.
Evolus, Inc. (EOLS) has a trailing twelve-month (TTM) P/E ratio of -6.14. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Evolus, Inc. (EOLS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Evolus, Inc. (EOLS) has a market capitalization of $319.44 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.